INVESTIGATION OF EFFECTS OF VITAMIN D AND VITAMIN D METABOLIZING CYP450 ISOZYMES ON MULTIPLE SCLEROSIS PATHOPHYSIOLOGY IN ANIMAL MODEL BY MOLECULAR APPROACHES

Download
2021-8
Evin, Emre
Multiple sclerosis (MS) is a complicated, recurrent, and often progressive inflammatory demyelinating autoimmune disease of the central nervous system, yet etiopathogenesis remains unsolved. MS frequency increases with increasing latitude, leading to a hypothesis that MS is inversely correlated with the duration and intensity of sunlight and vitamin D concentrations. In this study, the relationships between vitamin D supplementation, MS, VDR, and vitamin D metabolizing CYP enzymes, including CYP2R1, CYP27A1, CYP27B1, and CYP24A1 at mRNA and protein expression levels, were investigated by qRT-PCR and Western blotting techniques in female C57BL/6 mouse autoimmune encephalomyelitis (EAE) model. Both mRNA and protein expressions of Gr 1 were set to 1.00 fold, and expressions of the other groups were calculated relatively to Gr 1. At first, mice were divided into four groups; Gr 1 (control), Gr 2 (vitamin D supplemented control), Gr 3 (EAE), and Gr 4 (vitamin D supplemented EAE). According to the results of this study, vitamin D was not a preventive but a therapeutic agent since significantly higher numbers of mice were recovered in the Gr 4 (8 mice out of 12) than the Gr 3 (2 mice out of 12) (p=0.013<0.05). There was no statistically significant difference in CYP27A1 mRNA and protein expression among the groups. CYP2R1 mRNA expression was significantly low in Gr 4 (0.50 fold; p<0.05). However, CYP2R1 protein expression was not significantly different between the groups. CYP27B1 mRNA and protein expression were significantly high in Gr 2 and Gr 4 compared to Gr 3. CYP24A1 protein expression was higher in Gr 4 (1.70±0.46; p<0.05), which was positively correlated with the clinical score of the EAE. Although VDR mRNA expression increases with the EAE immunization, it was reverted in protein expression levels probably because of the post-transcriptional regulations by miRNAs. In conclusion, vitamin D supplementation and CYP24A1 inhibitor therapy may help to reduce the severity of MS symptoms.

Suggestions

Investigation of Glutathione S-Transferase (GST) expression and activity in mouse with Multiple Sclerosis (MS)
Arçak, Deniz; Adalı, Orhan; Evin, Emre; Department of Biology (2022-5-11)
Multiple Sclerosis (MS) of unknown etiopathogenesis is a chronic demyelinating disease of the central nervous system. It mainly destroys myelin in the brain and spinal cord. Non-traumatic injuries have been observed in this disease for young adults. Various factors affect MS, but oxidative stress is one of the most important causes of demyelination. Glutathione S- Transferases (GSTs) can be described as a versatile enzyme family of eukaryotic and prokaryotic phase II metabolic isoenzymes. They have enzymati...
Generation and Characterization of Induced Pluripotent Stem Cell Lines From Multiple Sclerosis Patients and Healthy Individuals
Begentaş, Onur Can; Kiriş, Erkan; Department of Molecular Biology and Genetics (2021-9-8)
Multiple Sclerosis (MS) is an autoimmune disease characterized by inflammation, demyelination, and axonal damage resulting in neurodegeneration in the central nervous system (CNS). Relapsing-remitting MS (RRMS) is the most common form of the disease known to affect more than 2 million individuals globally, and the prevalence of the disease is increasing worldwide. As a chronic condition without a cure, RRMS manifests in a relapsing-remitting form with sporadic attacks suddenly appearing, causing neurologica...
Relapsing-Remitting Multiple Sclerosis diagnosis from cerebrospinal fluids via Fourier transform infrared spectroscopy coupled with multivariate analysis
Yonar, Dilek; Ocek, Levent; Tiftikcioglu, Bedile Irem; Zorlu, Yasar; Severcan, Feride (2018-01-18)
Multiple sclerosis (MS) is a chronic, progressive, inflammatory and degenerative disease of central nervous system. Here, we aimed to develop a method for differential diagnosis of Relapsing-Remitting MS (RRMS) and clinically isolated syndrome (CIS) patients, as well as to identify CIS patients who will progress to RRMS, from cerebrospinal fluid (CSF) by infrared (IR) spectroscopy and multivariate analysis. Spectral analyses demonstrated significant differences in the molecular contents, especially in the l...
Association analysis of cholesterol 7-alpha hydroxylase (CYP7A1)and cholesterol 24-hydroxlase (CYP46A1) genetic polymorphisms and multiple sclerosis risk in Turkish population
Sezer, Eda; Kaya, Zeki; Department of Molecular Biology and Genetics (2019)
Multiple Sclerosis (MS) is the most common demyelinating disorder of the central nervous system. Under the effects of certain environmental factors, MS develops in genetically susceptible individuals. People with MS have significantly lower vitamin D levels. UV-B radiation catalyzes the photo-conversion of 7-dehydrocholesterol, produced in cholesterol production pathway, to vitamin D in the skin. Cholesterol 7α-hydroxylase (CYP7A1) in the liver and Cholesterol 24S-hydroxylase (CYP46A1) in the brain are resp...
Generation and characterization of human induced pluripotent stem cell line METUi001-A from a 25-year-old male patient with relapsing-remitting multiple sclerosis
Koc, Dilara; Begentaş, Onur Can; Yurtogullari, Sukran; Temel, Musa; Akcali, Kamil Can; Demirkaya, Seref; Kiriş, Erkan (2021-05-01)
Multiple sclerosis is a chronic disease characterized by inflammation, demyelination, and axonal damage in the central nervous system. Here, we established an induced pluripotent stem cell (iPSC) line METUi001-A from the peripheral blood mononuclear cells of a 25-year-old male individual with clinically diagnosed Relapsing-Remitting Multiple Sclerosis (RRMS) using the integration-free Sendai reprogramming method. We demonstrated that the iPSCs are free of exogenous Sendai reprogramming vectors, have a norma...
Citation Formats
E. Evin, “INVESTIGATION OF EFFECTS OF VITAMIN D AND VITAMIN D METABOLIZING CYP450 ISOZYMES ON MULTIPLE SCLEROSIS PATHOPHYSIOLOGY IN ANIMAL MODEL BY MOLECULAR APPROACHES,” Ph.D. - Doctoral Program, Middle East Technical University, 2021.